ADMA BIOLOGICS INC - COMMON STOCK

ADMA Biologics Announces Commercial Availability of Expanded Vial Size Offerings for BIVIGAM® and NABI-HB®

09 Aug 2021 06:00:01 By Nasdaq GlobeNewswire

ADMA Biologics to Report Second Quarter 2021 Financial Results on August 11, 2021

04 Aug 2021 06:00:03 By Nasdaq GlobeNewswire

ADMA Biologics Announces Successful Completion of FDA Pre-Approval Manufacturing Facility Inspection

20 Jul 2021 06:00:01 By Nasdaq GlobeNewswire

ADMA Biologics to Participate in the Raymond James Human Health Innovation Virtual Conference

14 Jun 2021 06:00:00 By Nasdaq GlobeNewswire

ADMA Biologics to Participate in the Jefferies Virtual Healthcare Conference

26 May 2021 06:00:01 By Nasdaq GlobeNewswire

ADMA Biologics Reports First Quarter 2021 Financial Results and Highlights Recent Company Progress and Accomplishments

12 May 2021 15:05:02 By Nasdaq GlobeNewswire

ADMA Biologics to Report First Quarter 2021 Financial Results on May 12, 2021

05 May 2021 06:00:01 By Nasdaq GlobeNewswire

ADMA Biologics Receives FDA Approval for Increased IVIG Production Scale

28 Apr 2021 06:00:00 By Nasdaq GlobeNewswire

ADMA Biologics Opens Newest ADMA BioCenters Plasma Collection Facility in Goose Creek, S.C.

26 Apr 2021 07:00:02 By Nasdaq GlobeNewswire

ADMA Biologics Announces Poster Presentation Highlighting Pharmacoeconomic Burden of HIV and HBV Infection in Sexual Assault Patients at the 2021 Academy of Managed Care Pharmacy Virtual Annual Meeting

13 Apr 2021 07:00:01 By Nasdaq GlobeNewswire

ADMA Biologics Reports Fourth Quarter and Full Year 2020 Financial Results

25 Mar 2021 15:05:01 By Nasdaq GlobeNewswire

ADMA Biologics to Report Fourth Quarter and Full Year 2020 Financial Results on March 25, 2021

18 Mar 2021 07:00:00 By Nasdaq GlobeNewswire

ADMA Biologics to Participate in the Jefferies Virtual Plasma Summit

04 Mar 2021 07:00:02 By Nasdaq GlobeNewswire

ADMA Biologics Expands Global Regulatory Approval Presence and Announces FDA Approval to Commence Hepatitis B Plasma Collections

03 Mar 2021 07:00:01 By Nasdaq GlobeNewswire

ADMA Biologics Presents Late-Breaking Poster Presentation Highlighting Clinical Utility of S. Pneumoniae Hyperimmune Globulin at the 2021 American Academy of Allergy, Asthma & Immunology Virtual Annual Meeting

26 Feb 2021 07:00:00 By Nasdaq GlobeNewswire

ADMA Biologics Receives FDA Approval for ADMA BioCenters Plasma Collection Facility in Knoxville, TN

01 Feb 2021 07:00:01 By Nasdaq GlobeNewswire

ADMA Biologics Receives Unique Permanent J-Code for ASCENIV™

26 Jan 2021 07:00:02 By Nasdaq GlobeNewswire

ADMA Biologics Announces Preliminary Fourth Quarter and Full Year 2020 Revenues and Provides 2021 Strategic Outlook

19 Jan 2021 07:00:01 By Nasdaq GlobeNewswire

ADMA Biologics Receives Unique Temporary C-Code and Pass-Through Payment Status for ASCENIV™

04 Jan 2021 07:00:01 By Nasdaq GlobeNewswire